Advances in cancer epidemiology in Japan

International Journal of Cancer

Volumn 134, Issue 4, 2014, Pages 747-754

  Tanaka, Hideo ^a,b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

cancer incidence; cancer survival; case control study; coffee; descriptive epidemiology; Japan; molecular epidemiology

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALDEHYDE DEHYDROGENASE ISOENZYME 2;

ALDH2 GENE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; COHORT ANALYSIS; COLORECTAL CANCER; DRINKING BEHAVIOR; ESOPHAGUS CANCER; GENE LOCUS; GENOTYPE ENVIRONMENT INTERACTION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; JAPAN; JAPANESE; LIVER CANCER; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR EPIDEMIOLOGY; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; STOMACH CANCER; SURVIVAL RATE;

EID: 84890122909     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28519     Document Type: Review

References (72)

1. Hirayama T,. Non-smoking wives of heavy smokers have a higher risk of lung cancer: a study from Japan. Br Med J (Clin Res Ed) 1981; 282: 183-5.
2. Matsuda A, Matsuda T, Shibata A, et al. Cancer incidence and incidence rates in Japan in 2007: a study of 21 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 2013; 43: 328-36.
3. Hosokawa M, Imazeki S, Mizunuma H, et al. Secular trends in age at menarche and time to establish regular menstrual cycling in Japanese women born between 1930 and 1985. BMC Womens Health 2012; 12: 19. www.biomedcentral.com/ 1472-6874/12/19.
4. Katanoda K, Ajiki W, Matsuda T, et al. Trend analysis of cancer incidence in Japan using data from selected population-based cancer registries. Cancer Sci 2012; 103: 360-8.
5. Ito H, Matsuo K, Tanaka H, et al. Nonfilter and filter cigarette consumption and the incidence of lung cancer by histological type in Japan and the United States: analysis of 30-year data from population-based cancer registries. Int J Cancer 2011; 128: 1918-28.
6. Tanaka H, Imai Y, Hiramatsu N, et al. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann Intern Med 2008; 148: 820-6.
7. Tanaka H, Uera F, Tsukuma H, et al. Distinctive change in male liver cancer incidence rate between the 1970s and 1990s in Japan: comparison with Japanese-Americans and US whites. Jpn J Clin Oncol 2007; 37: 193-6.
8. Tanaka Y, Kurbanov F, Mano S, et al. Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. Gastroenterology 2006; 130: 703-14.
9. Tanaka M, Ma E, Tanaka H, et al. Trends of stomach cancer mortality in Eastern Asia in 1950-2004: comparative study of Japan, Hong Kong and Singapore using age, period and cohort analysis. Int J Cancer 2012; 130: 930-6.
10. Tsukuma H, Ajiki W, Ioka A, et al. Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. Jpn J Clin Oncol 2006; 36: 602-7.
11. Tanaka H, Tanaka M, Chen W, et al. Proposal for a cooperative study on population-based cancer survival in selected registries in East Asia. Asian Pac J Cancer Prev 2009; 10: 1191-8.
12. Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008; 9: 730-56.
13. Corazziari I, Quinn M, Capocaccia R,. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004; 40: 2307-16.
14. Sobue T, Inoue M, Tanaka H,. Cancer Registry and Epidemiological Study Working Group report. Jpn J Clin Oncol 2010; 40 (Suppl 1): i76-81.
15. Ito Y, Nakayama T, Tsukuma H, et al. Role of age and tumour stage in the temporal pattern of 'cure' from stomach cancer: a population-based study in Osaka, Japan. Cancer Epidemiol 2012; 36: 128-32.
16. Ito Y, Nakayama T, Miyashiro I, et al. Trends in "cure" fraction from colorectal cancer by age and tumour stage between 1975 and 2000, using population-based data, Osaka, Japan. Jpn J Clin Oncol 2012; 42: 974-83.
17. Oze I, Matsuo K, Ito H, et al. Cigarette smoking and esophageal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2012; 42: 63-73.
18. Mizoue T, Inoue M, Tanaka K, et al. Tobacco smoking and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2006; 36: 25-39.
19. Tanaka K, Tsuji I, Wakai K, et al. Cigarette smoking and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among Japanese. Jpn J Clin Oncol 2006; 36: 445-56.
20. Matsuo K, Ito H, Wakai K, et al. Cigarette smoking and pancreas cancer risk: an evaluation based on a systematic review of epidemiologic evidence in the Japanese population. Jpn J Clin Oncol 2011; 41: 1292-302.
21. Inoue M, Wakai K, Nagata C, et al. Alcohol drinking and total cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2007; 37: 692-700.
22. Oze I, Matsuo K, Wakai K, et al. Alcohol drinking and esophageal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2011; 41: 677-92.
23. Shimazu T, Tsuji I, Inoue M, et al. Alcohol drinking and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2008; 38: 8-25.
24. Mizoue T, Tanaka K, Tsuji I, et al. Alcohol drinking and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2006; 36: 582-97.
25. Tanaka K, Tsuji I, Wakai K, et al. Alcohol drinking and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2008; 38: 816-38.
26. Wakai K, Nagata C, Mizoue T, et al. Alcohol drinking and lung cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2007; 37: 168-74.
27. Nagata C, Mizoue T, Tanaka K, et al. Alcohol drinking and breast cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2007; 37: 568-74.
28. Wakai K, Matsuo K, Nagata C, et al. Lung cancer risk and consumption of vegetables and fruit: an evaluation based on a systematic review of epidemiological evidence from Japan. Jpn J Clin Oncol 2011; 41: 693-708.
29. Sasazuki S, Tamakoshi A, Matsuo K, et al. Green tea consumption and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2012; 42: 335-46.
30. Pham NM, Mizoue T, Tanaka K, et al. Physical activity and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2012; 42: 2-13.
31. Tanaka K, Tsuji I, Tamakoshi A, et al. Obesity and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2012; 42: 212-21.
32. Sasazuki S, Inoue M, Tsuji I, et al. Body mass index and mortality from all causes and major causes in Japanese: results of a pooled analysis of 7 large-scale cohort studies. J Epidemiol 2011; 21: 417-30.
33. Nagata C, Mizoue T, Tanaka K, et al. Breastfeeding and breast cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2012; 42: 124-30.
34. Song M, Rolland B, Potter JD, et al. Asia Cohort Consortium: challenges for collaborative research. J Epidemiol 2012; 22: 287-90.
35. Zheng W, McLerran DF, Rolland B, et al. Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med 2011; 364: 719-29.
36. Boffetta P, McLerran D, Chen Y, et al. Body mass index and diabetes in Asia: a cross-sectional pooled analysis of 900,000 individuals in the Asia cohort consortium. PLoS One 2011; 6: e19930.
37. Boffetta P, Hazelton WD, Chen Y, et al. Body mass, #tobacco |smoking, alcohol drinking and risk of cancer of the small intestine-a pooled analysis of over 500,000 subjects in the Asia Cohort Consortium. Ann Oncol 2012; 23: 1894-8.
38. Lin Y, Fu R, Grant E, et al. Association of body mass index and risk of death from pancreas cancer in Asians: findings from the Asia Cohort Consortium. Eur J Cancer Prev 2013; 22: 244-50.
39. Porta M, Vioque J, Ayude D, et al. Coffee drinking: the rationale for treating it as a potential effect modifier of carcinogenic exposures. Eur J Epidemiol 2003; 18: 289-98.
40. Inoue M, Yoshimi I, Sobue T, et al. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 2005; 97: 293-300.
41. Shimazu T, Tsubono Y, Kuriyama S, et al. Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int J Cancer 2005; 116: 150-4.
42. Kurozawa Y, Ogimoto I, Shibata A, et al. Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer 2005; 93: 607-10.
43. Bravi F, Bosetti C, Tavani A, et al. Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology 2007; 46: 430-5.
44. Ohfuji S, Fukushima W, Tanaka T, et al. Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: a case-control study. Hepatol Res 2006; 36: 201-8.
45. Tanaka K, Hara M, Sakamoto T, et al. Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case-control study in Japan. Cancer Sci 2007; 98: 214-8.
46. Ohishi W, Fujiwara S, Cologne JB, et al. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2008; 17: 846-54.
47. Inoue M, Kurahashi N, Iwasaki M, et al. Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status. Cancer Epidemiol Biomarkers Prev 2009; 18: 1746-53.
48. Je Y, Liu W, Giovannucci E,. Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective cohort studies. Int J Cancer 2009; 124: 1662-8.
49. Oba S, Shimizu N, Nagata C, et al. The relationship between the consumption of meat, fat, and coffee and the risk of colon cancer: a prospective study in Japan. Cancer Lett 2006; 244: 260-7.
50. Naganuma T, Kuriyama S, Akhter M, et al. Coffee consumption and the risk of colorectal cancer: a prospective cohort study in Japan. Int J Cancer 2007; 120: 1542-7.
51. Lee KJ, Inoue M, Otani T, et al. Coffee consumption and risk of colorectal cancer in a population-based prospective cohort of Japanese men and women. Int J Cancer 2007; 121: 1312-8.
52. Je Y, Giovannucci E,. Coffee consumption and risk of endometrial cancer: findings from a large up-to-date meta-analysis. Int J Cancer 2012; 131: 1700-10.
53. Hirose K, Niwa Y, Wakai K, et al. Coffee consumption and the risk of endometrial cancer: evidence from a case-control study of female hormone-related cancers in Japan. Cancer Sci 2007; 98: 411-5.
54. Koizumi T, Nakaya N, Okamura C, et al. Case-control study of coffee consumption and the risk of endometrial endometrioid adenocarcinoma. Eur J Cancer Prev 2008; 17: 358-63.
55. Shimazu T, Inoue M, Sasazuki S, et al. Coffee consumption and risk of endometrial cancer: a prospective study in Japan. Int J Cancer 2008; 123: 2406-10.
56. Tajima K, Hirose K, Inoue M, et al. A model of practical cancer prevention for out-patients visiting a hospital: the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Asian Pac J Cancer Prev 2000; 1: 35-47.
57. Matsuo K, Hamajima N, Shinoda M, et al. Gene-environment interaction between an aldehyde dehydrogenase-2 (ALDH2) polymorphism and alcohol consumption for the risk of esophageal cancer. Carcinogenesis 2001; 22: 913-6.
58. Park JY, Matsuo K, Suzuki T, et al. Impact of smoking on lung cancer risk is stronger in those with the homozygous aldehyde dehydrogenase 2 null allele in a Japanese population. Carcinogenesis 2010; 31: 660-5.
59. Suzuki T, Matsuo K, Sawaki A, et al. Alcohol drinking and one-carbon metabolism-related gene polymorphisms on pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev 2008; 17: 2742-7.
60. Sueta A, Ito H, Kawase T, et al. A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population. Breast Cancer Res Treat 2012; 132: 711-21.
61. Lan Q, Hsiung CA, Matsuo K, et al. Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet 2012; 44: 1330-5.
62. Jia WH, Zhang B, Matsuo K, et al. Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer. Nat Genet 2013; 45: 191-6.
63. Zheng W, Zhang B, Cai Q, et al. Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls. Hum Mol Genet 2013; 22: 2539-50.
64. Matsuo K, Ito H, Yatabe Y, et al. Risk factors differ for non-small-cell lung cancers with and without EGFR mutation: assessment of smoking and sex by a case-control study in Japanese. Cancer Sci 2007; 98: 96-101.
65. Hamajima N,. The Japan Multi-Institutional Collaborative Cohort Study (J-MICC Study) to detect gene-environment interactions for cancer. Asian Pac J Cancer Prev 2007; 8: 317-23.
66. Wakai K, Hamajima N, Okada R, et al. Profile of participants and genotype distributions of 108 polymorphisms in a cross-sectional study of associations of genotypes with lifestyle and clinical factors: a project in the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study. J Epidemiol 2011; 21: 223-35.
67. Okada R, Wakai K, Naito M, et al. Pro-/anti-inflammatory cytokine gene polymorphisms and chronic kidney disease: a cross-sectional study. BMC Nephrol 2012; 13: 2. www.biomedcentral.com/1471-2369/13/2.
68. Okada R, Kawai S, Naito M, et al. Matrix metalloproteinase-9 gene polymorphisms and chronic kidney disease. Am J Nephrol 2012; 36: 444-50.
69. Hiyoshi M, Uemura H, Arisawa K, et al. Association between the catechol-O-methyltransferase (rs4680: Val158Met) polymorphism and serum alanine aminotransferase activity. Gene 2012; 496: 97-102.
70. Hara M, Higaki Y, Taguchi N, et al. Effect of the PPARG2 Pro12Ala polymorphism and clinical risk factors for diabetes mellitus on HbA1c in the Japanese general population. J Epidemiol 2012; 22: 523-31.
71. Hishida A, Morita E, Naito M, et al. Associations of apolipoprotein A5 (APOA5), glucokinase (GCK) and glucokinase regulatory protein (GCKR) polymorphisms and lifestyle factors with the risk of dyslipidemia and dysglycemia in Japanese-a cross-sectional data from the J-MICC study. Endocr J 2012; 59: 589-99.
72. Uemura H, Hiyoshi M, Arisawa K, et al. Gene variants in PPARD and PPARGC1A are associated with timing of natural menopause in the general Japanese population. Maturitas 2012; 71: 369-75.